Probabilistic sensitivity analysis indicated that 99.98% of simulations were below the threshold for cost-effectiveness.<h4>Conclusion</h4>Stratified isoniazid dosing by NAT2 genotype would be cost-effective in treatment of pulmonary tuberculosis in Thailand. This evidence concerns the gene NAT2 and pulmonary tuberculosis.